Debt and Financing - Additional Information (Details) - USD ($)					12 Months Ended
	Jan. 15, 2021	Jul. 07, 2020	Sep. 11, 2019	Jan. 31, 2018	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2021	Dec. 31, 2019	Dec. 31, 2020	Feb. 13, 2014
Debt Instrument [Line Items]
Common stock, shares issued							50,955,000		50,192,000
Contribution rate of subsidiaries to funds								25.00%
Minimum | 2014 ABL Facility Credit Agreement
Debt Instrument [Line Items]
Commitment fee percentage							0.25%
Maximum | 2014 ABL Facility Credit Agreement
Debt Instrument [Line Items]
Commitment fee percentage							0.375%
2014 ABL Facility Credit Agreement
Debt Instrument [Line Items]
Principal amount issued										$ 450,000,000
Basis spread on variable rate							2.25%
2014 ABL Facility Credit Agreement | Alternate Base Rate
Debt Instrument [Line Items]
Basis spread on variable rate							1.25%
Term Loan
Debt Instrument [Line Items]
Principal amount issued			$ 600,000,000.0
Basis spread on variable rate			7.50%				14.00%
Margin step down if certain EBITDA is achieved			1.00%
Term Loan | Minimum
Debt Instrument [Line Items]
Adjusted EBITDA threshold for margin step down			$ 400,000,000.0
Term Loan | Eurodollar
Debt Instrument [Line Items]
Floor interest rate			1.00%
ABL Facility | Minimum | 2014 ABL Facility Credit Agreement
Debt Instrument [Line Items]
Interest rate							2.25%
UST Credit Agreement
Debt Instrument [Line Items]
Principal amount issued		$ 700,000,000.0
Debt instrument maturity date		Sep. 30, 2024
Minimum adjusted EBITDA							$ 100,000,000.0
Common stock, shares issued							15,943,753
Fair value of common stock shares issued							$ 46,700,000
Debt issuance costs incurred for origination and legal fees		$ 12,200,000
Expenses qualifying as adjustment cap, percent							10.00%
Adjusted EBITDA expenses qualifying as adjustment cap, percent							10.00%
UST Credit Agreement | 2014 ABL Facility Credit Agreement
Debt Instrument [Line Items]
Increase in interest rate		0.50%
UST Credit Agreement | Forecast
Debt Instrument [Line Items]
Minimum adjusted EBITDA						$ 150,000,000.0
Minimum adjusted EBITDA thereafter					$ 200,000,000.0
UST Credit Agreement | Tranche A
Debt Instrument [Line Items]
Principal amount issued		$ 300,000,000.0
Percentage of paid in kind remainder		1.50%
UST Credit Agreement | Tranche A | Eurodollar
Debt Instrument [Line Items]
Basis spread on variable rate		3.50%
Floor interest rate		1.00%
UST Credit Agreement | Tranche B
Debt Instrument [Line Items]
Principal amount issued		$ 400,000,000.0
UST Credit Agreement | Tranche B | Eurodollar
Debt Instrument [Line Items]
Basis spread on variable rate		3.50%
Floor interest rate		1.00%
Second Term Loan Amendment | Term Loan | Eurodollar
Debt Instrument [Line Items]
Basis spread on variable rate		7.50%
Second Term Loan Amendment | Term Loan | Alternate Base Rate
Debt Instrument [Line Items]
Basis spread on variable rate		6.50%
Amended Second A&R CDA
Debt Instrument [Line Items]
Debt instrument maturity date				Dec. 31, 2022
Annual amortization of amount outstanding, percent				2.00%
2014 ABL Facility Credit Agreement
Debt Instrument [Line Items]
Line of credit facility, total cash and availability							$ 93,100,000
Managed accessibility							48,100,000		$ 4,000,000.0
Cash, cash equivalents and managed accessibility							358,800,000		440,200,000
2014 ABL Facility Credit Agreement | Letter of Credit
Debt Instrument [Line Items]
Letters of credit outstanding, amount							$ 356,900,000
Collateral line cap, percent	10.00%						10.00%
Restricted cash	$ 3,100,000
2014 ABL Facility Credit Agreement | ABL Facility
Debt Instrument [Line Items]
Line of credit facility, total cash and availability									$ 43,700,000